Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 44Breast Neoplasms 26Sarcoma 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Burkitt Lymphoma 14Neuroblastoma 13Hodgkin Disease 13Leukemia 12Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Follicular 8Wilms Tumor 7Sarcoma, Synovial 7Neurofibrosarcoma 7Leiomyosarcoma 7Histiocytoma, Malignant Fibrous 7Hemangiosarcoma 7Fibrosarcoma 7Endometrial Neoplasms 7Urinary Bladder Neoplasms 6Multiple Myeloma 6Malignant mesenchymal tumor 6Liposarcoma 6Rhabdomyosarcoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Anaplastic 5Kidney Neoplasms 5Hemangiopericytoma, Malignant 5Waldenstrom Macroglobulinemia 4Sarcoma, Alveolar Soft Part 4

Interventions

lorvotuzumab mertansine 1Watchful Waiting 1Vincristine 1Topotecan 1Specimen Handling 1Razoxane 1Polymerase Chain Reaction 1Observation 1Magnetic Resonance Spectroscopy 1Ifosfamide 1High-Energy Shock Waves 1Gene Rearrangement 1Gene Expression Profiling 1Doxorubicin 1Dexrazoxane 1Dactinomycin 1Cytogenetic Analysis 1Cyclophosphamide 1Amplified Fragment Length Polymorphism Analysis 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pleuropulmonary blastoma × Doxorubicin × Clear all
NCT06647953 2026-05-05

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Children's Oncology Group

Phase 3 Recruiting
110 enrolled

Pleuropulmonary blastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡